Related references
Note: Only part of the references are listed.Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab
Christine Fuja et al.
TRANSFUSION (2022)
Blood Transfusion Reactions-A Comprehensive Review of the Literature including a Swiss Perspective
Theresa Ackfeld et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature
Sasmith R. Menakuru et al.
HEMATOLOGY REPORTS (2022)
A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β-thalassemia during perinatal transfusion
Yuanjun Wu et al.
TRANSFUSION MEDICINE (2021)
Management of hemolytic transfusion reactions
Jeanne E. Hendrickson et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)
Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration
Giovanna Cannas et al.
AMERICAN JOURNAL OF CASE REPORTS (2021)
Posttransfusion hyperhemolysis is arrested by targeting macrophage activation with novel use of Tocilizumab
Lauren E. Lee et al.
TRANSFUSION (2020)
Can we better predict delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease?
Brian D. Adkins et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Role of complement in alloimmunization and hyperhemolysis
Satheesh Chonat et al.
CURRENT OPINION IN HEMATOLOGY (2020)
Accelerated erythrocyte destruction mimicking post-transfusion hyperhaemolysis in the course of uncomplicated vaso-occlusive crisis associated with sickle cell disease
Marina C. A. V. Conrado et al.
TRANSFUSION MEDICINE (2020)
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
Stella T. Chou et al.
BLOOD ADVANCES (2020)
Histopathological evidence for macrophage activation driving post-transfusion hyperhaemolysis syndrome
Nay Win et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Successful management of the potentially fatal hyperhaemolysis syndrome of sickle cell anaemia with a regimen including bortezomib and Hemopure
Stacy S. Epstein et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Treatment of post-transfusion hyperhaemolysis syndrome in Sickle Cell Disease with the anti-IL6R humanised monoclonal antibody Tocilizumab
Suthesh Sivapalaratnam et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction
Lubka T. Roumenina et al.
TRANSFUSION MEDICINE REVIEWS (2019)
Whole-exome sequencing of sickle cell disease patients with hyperhemolysis syndrome suggests a role for rare variation in disease predisposition
Savannah Mwesigwa et al.
TRANSFUSION (2018)
A fatal case of immune hyperhemolysis with bone marrow necrosis in a patient with sickle cell disease
Matthew S. Karafin et al.
HEMATOLOGY REPORTS (2017)
Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series
Robert Sheppard Nickel et al.
TRANSFUSION (2016)
Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes
Anoosha Habibi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Hyperhemolysis in Patients With Hemoglobinopathies: A Single-Center Experience and Review of the Literature
Anicee Danaee et al.
TRANSFUSION MEDICINE REVIEWS (2015)
Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab
Shruti Gupta et al.
TRANSFUSION (2015)
BLOOD TRANSFUSION IN SICKLE CELL DISEASE
Rajaa Marouf
HEMOGLOBIN (2011)
Hyperhemolysis syndrome in sickle cell disease
Nay Win
EXPERT REVIEW OF HEMATOLOGY (2009)
Share Paper
